First Page | Meta Content | |
---|---|---|
![]() | Document Date: 2012-06-20 15:38:04Open Document File Size: 671,78 KBShare Result on FacebookCompanyNIOSH Working Group / Technical Assistance Bulletin / /ContinentAmerica / /CountryUnited States / / /EventProduct Issues / FDA Phase / /FacilityDEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention National Institute / National Institute / /IndustryTermtest systems / transportation / pharmaceuticals / pharmaceutical industry / short-term test systems / clean equipment / patient care by participating in product / in vitro systems / radio-pharmaceuticals / /MedicalConditionnonmalignant diseases / serious diseases / cancer / rheumatoid arthritis / multiple sclerosis / /MedicalTreatmentantibiotics / chemotherapy / /OrganizationDEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention National Institute for Occupational Safety / Nuclear Regulatory Agency / U.S. Food and Drug Administration / US Federal Reserve / Institute for Occupational Safety / Occupational Safety and Health Administration / Environmental Protection Agency / International Agency for Research / /PositionDrugs Considered Hazardous General / /ProductCarboplatin / Bicalutamide / cyclophosphamide / Carbamazepine / Alert / Cabergoline / Vitamin A / Azathioprine / Chloramphenicol / Anastrozole / Crushing tablets / drugs Examples / General Approach / Drugs / Drugs The / Drugs In / Drugs ASHP / drug / drugs* / drug list / /TechnologyDNA synthesis / chemotherapy / http / drug development / pdf / /URLhttp /SocialTag |